CHRISTINA ONDERCIN: Open Payments
NPI 1053793497 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 12 payments from 8 companies in 2025. Trend: 2023 $104 · 2024 $331 · 2025 $701
Food & beverage: $701
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $371 |
| GENZYME CORPORATION | 1 | $121 |
| Novo Nordisk Inc | 2 | $119 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Corcept Therapeutics | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: AIRSUPRA, DUPIXENT, Wegovy, BREZTRI, FARXIGA, XIFAXAN, Korlym, UBRELVY.
Industry payments across IN — which companies pay providers there.
